416 filings
S-4/A
ONC
BeiGene, Ltd.
21 Jan 25
Registration of securities issued in business combination transactions (amended)
4:06pm
8-K
ONC
BeiGene, Ltd.
13 Jan 25
Regulation FD Disclosure
5:02pm
10-K/A
2023 FY
ONC
BeiGene, Ltd.
8 Jan 25
Annual report (amended)
6:02am
8-K
ONC
BeiGene, Ltd.
23 Dec 24
Other Events
6:05am
8-K
ONC
BeiGene, Ltd.
10 Dec 24
Entry into a Material Definitive Agreement
6:02am
8-K
p6i u7jvqakvyrr
19 Nov 24
Other Events
6:03am
8-K
cgd2vd2
14 Nov 24
Other Events
6:05am
8-K
jl5 bnamqnqvkbyvm8
12 Nov 24
BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
6:03am
8-K
kgbea5iil1d res
28 Oct 24
Other Events
6:05am
8-K
mjltvhgjuhqi 1xvian
30 Sep 24
Other Events
6:02am
8-K
6eipqx 8kj
26 Sep 24
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
6:12am
8-K
3vqe6yl
29 Aug 24
Results of Operations and Financial Condition
7:29am
S-4
0c5f6i6gtr ozog
7 Aug 24
Registration of securities issued in business combination transactions
7:32am
8-K
kyqx4rx40 y6chk
7 Aug 24
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
6:04am
8-K
040folgtpta
18 Jul 24
BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer
6:40am
S-8
96ytoo6
5 Jun 24
Registration of securities for employees
5:23pm
8-K
ofr0h73
5 Jun 24
Departure of Directors or Certain Officers
4:35pm